サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1624399

軟骨修復-軟骨再生の世界市場規模：用途別、治療モダリティ別、地域別、範囲および予測

Global Cartilage Repair-Cartilage Regeneration Market Size By Application, By Treatment Modality, By Geographic Scope And Forecast

出版日
ページ情報
英文 202 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
軟骨修復-軟骨再生の世界市場規模：用途別、治療モダリティ別、地域別、範囲および予測
出版日: 2024年11月22日
発行: Verified Market Research
ページ情報: 英文 202 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

軟骨修復-軟骨再生の市場規模と予測

軟骨修復-軟骨再生市場規模は、2019年に6億65万米ドルと評価され、2020年から2027年にかけて13.43%のCAGRで成長し、2027年には15億3,569万米ドルに達すると予測されます。

変形性関節症のような骨・関節疾患の増加、スポーツ傷害の増加、軟骨再生における技術的進歩が、予測される年月にわたって軟骨修復-軟骨再生市場を牽引すると予想されます。軟骨修復-軟骨再生の世界市場レポートは、市場の全体的な評価を提供します。主要セグメント、動向、市場促進要因、抑制要因、競合情勢、市場で重要な役割を果たしている要因などを包括的に分析しています。

世界の軟骨修復-軟骨再生市場の定義

軟骨修復-軟骨再生は、健康であるが損傷した軟骨を持つための関節治療です。軟骨は、機能障害や痛みを引き起こす傷害によって損傷します。血液供給不足は軟骨損傷の理由のひとつです。

変形性関節症の開発は、軟骨の修復または再生方法を早期に採用することで予防できます。用途により、軟骨修復・再生と線維軟骨修復・再生に分類されます。治療方法には、細胞ベースのアプローチ、軟骨細胞移植、成長因子技術、幹細胞、非細胞ベースのアプローチ、組織足場、無細胞複合材料など様々な種類があります。

軟骨修復-軟骨再生の世界市場概要

変形性関節症のような骨・関節疾患の罹患率の上昇と軟骨再生における技術的進歩が、予測される年月にわたって軟骨修復-軟骨再生市場を牽引すると予想されます。また、老年人口の増加やスポーツ傷害の増加が、今後数年間で市場を押し上げると予想されます。さらに、糖尿病の有病率の増加は、予測期間中に市場を促進すると予測されています。市場成長を阻害する要因や課題もあります。不利な償還シナリオや治療費の高騰といった要因が市場抑制要因として作用する可能性が高いです。

目次

第1章 軟骨修復-軟骨再生の世界市場：イントロダクション

  • 市場概要
  • 調査範囲
  • 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

  • データマイニング
  • バリデーション
  • 一次資料
  • データソース一覧

第4章 世界の軟骨修復-軟骨再生市場の展望

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • ポーターのファイブフォースモデル
  • バリューチェーン分析
  • 規制の枠組み

第5章 軟骨修復-軟骨再生の世界市場：用途別

  • 概要
  • ヒアルロン酸軟骨の修復と再生
  • 線維軟骨の修復と再生

第6章 軟骨修復-軟骨再生の世界市場：治療モダリティ別

  • 概要
  • 細胞ベースのアプローチ
  • 軟骨細胞移植
  • 成長因子技術
  • 幹細胞
  • 非細胞ベースのアプローチ
  • 組織足場
  • 無細胞複合材料

第7章 軟骨修復-軟骨再生の世界市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第8章 世界の軟骨修復-軟骨再生市場：競合情勢

  • 概要
  • 企業市場シェア
  • ベンダー情勢
  • 主な発展戦略

第9章 企業プロファイル

  • Zimmer Biomet Holdings, Inc.
  • DepuySynthes（Johnson & Johnson Company）
  • Vericel Corporation
  • Smith & Nephew PLC
  • Osiris Therapeutics, Inc.
  • Arthrex, Inc.
  • RTI Surgical
  • ConmedLinvatec
  • LAnika Therapeutics S. R. L.
  • B. Braun Melsungen AG

第10章 付録

  • 関連調査
目次
Product Code: 24169

Cartilage Repair-Cartilage Regeneration Market Size And Forecast

Cartilage Repair-Cartilage Regeneration Market size was valued at USD 600.65 Million in 2019 and is projected to reachUSD 1535.69 Million by 2027, growing at aCAGR of 13.43% from 2020 to 2027.

The rising incidences of bone & joint disorders like osteoarthritis, the growing number of sports injuries, and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. The Global Cartilage Repair-Cartilage Regeneration Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cartilage Repair-Cartilage Regeneration Market Definition

Cartilage Repair-Cartilage Regeneration Is a Joint Treatment for Having Healthy but Damaged Cartilage. the Cartilage Gets Damaged Due to Injury-Causing Impaired Function and Pain. a Direct Blow, Progressive Degeneration, and Traumatic Injury Are Some of The Reasons for Articular Cartilage Injuries. the Progressive Loss of Structure and Function of The Cartilage Causes Degeneration of Cartilage. Lack of Blood Supply Is One of The Reasons for Cartilage Damage.

Development of Osteoarthritis Can Be Prevented by Early Adoption of Cartilage Restoration or Regeneration Methods. Based on The Application, the Market Can Be Classified Into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. Various Types of Treatment Modalities Are Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cartilage Repair-Cartilage Regeneration Market Overview

The rising incidences of bone & joint disorders like osteoarthritis and technological advancements in cartilage regeneration are expected to drive the Cartilage Repair-Cartilage Regeneration Market over the predicted years. Also, the increasing geriatric population and the growing number of sports injuries expect a boost to the market in the coming years. Additionally, the growing prevalence of diabetes is predicted to fuel the market during the forecasted period. There are certain restraints and challenges faced which can hinder market growth. Factors such as unfavorable reimbursement scenarios and higher costs of therapy are likely to act as market restraints.

Global Cartilage Repair-Cartilage Regeneration Market: Segmentation Analysis

The Global Cartilage Repair-Cartilage Regeneration Market is Segmented on the basis of Application, Treatment Modality, And Geography.

Cartilage Repair-Cartilage Regeneration Market, By Application

  • Hyaline Cartilage Repair and Regeneration
  • Fibrocartilage Repair and Regeneration

Based on Application, the market is bifurcated into Hyaline Cartilage Repair and Regeneration and Fibrocartilage Repair and Regeneration. The Hyaline Cartilage Repair and Regeneration segment is expected to hold the largest market share. The factors can be attributed to the increasing incidents of physical trauma all over the world.

Cartilage Repair-Cartilage Regeneration Market, By Treatment Modality

  • Cell-Based Approaches
  • Chondrocyte Transplantation
  • Growth Factor Technology
  • Stem Cells
  • Non-Cell-Based Approaches
  • Tissue Scaffolds
  • Cell-Free Composites

Based on Treatment Modality, the market is bifurcated into Cell-Based Approaches, Chondrocyte Transplantation, Growth Factor Technology, Stem Cells, Non-Cell-Based Approaches, Tissue Scaffolds, and Cell-Free Composites. Cell-Based Approaches are predicted to hold the most significant CAGR in the forecasted period due to the technological advancements in stem cell-based therapies for cartilage repair and chondrocyte implantation products.

Cartilage Repair-Cartilage Regeneration Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on regional analysis, the Global Cartilage Repair-Cartilage Regeneration Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by the Asia Pacific owing to the rise in incidences of various disorders & injuries and the increasing geriatric population in this region.

Key Players

  • The "Global Cartilage Repair-Cartilage Regeneration Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market Such As
  • Zimmer Biomet Holdings, Inc., DepuySynthes (Johnson & Johnson Company), Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., Arthrex, Inc., RTI Surgical, ConmedLinvatec, Anika Therapeutics S. R. L., B. Braun Melsungen AG.
  • These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Hyaline Cartilage Repair and Regeneration
  • 5.3 Fibrocartilage Repair and Regeneration

6 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY

  • 6.1 Overview
  • 6.2 Cell-Based Approaches
  • 6.3 Chondrocyte Transplantation
  • 6.4 Growth Factor Technology
  • 6.5 Stem Cells
  • 6.6 Non-Cell-Based Approaches
  • 6.7 Tissue Scaffolds
  • 6.8 Cell-Free Composites

7 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL CARTILAGE REPAIR-CARTILAGE REGENERATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Zimmer Biomet Holdings, Inc.
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 DepuySynthes (Johnson & Johnson Company)
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Vericel Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Smith & Nephew PLC
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Osiris Therapeutics, Inc.
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Arthrex, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 RTI Surgical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConmedLinvatec
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 LAnika Therapeutics S. R. L.
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 B. Braun Melsungen AG
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Research